Research and Development

Aurobindo pharma has major investments in R&D with facilities in Hyderabad, India & New Jersey, United States.

Our centres cover over 13000 square meters of the R&D laboratories with a dedicated team of scientists working constantly developing products to improve quality, efficacy and streamline production costs to satisfy the global needs.

The centre meets “current good laboratory practice” (cGLP) requirements and is focused on the areas of
organic synthesis, analytical research, dosage form development, pharmacology, bio-equivalence studies
and drug delivery systems.

With over 300 generic drugs approved globally, Aurobindo pharma is committed to continuing a pipeline of products to meet the market & patient’s needs. We have recently commenced global development work to enter into the non-penicillins, non-cephalosporin (NPNC) based injectable markets.

 

 

Copyright © Auro Pharma.